Checking authentication...
Macleods Pharma Shares
Macleods Pharmaceuticals Ltd is a prominent global pharmaceutical company established in 1989, headquartered in Mumbai, India. The company is engaged in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations across various therapeutic areas.
Fundamentals
Financial (In Cr)
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 8217 | 8223 | 6451 | - |
| Cost of Material Consumed | TBD | - | - | - |
| Gross Margins | 0.61 | - | - | - |
| Change in Inventory | TBD | - | - | - |
| Employee Benefit Expenses | TBD | - | - | - |
| Other Expenses | TBD | - | - | - |
| EBITDA | 1758 | 1714 | 1540 | - |
| OPM | 0.22 | - | - | - |
| Other Income | - | - | - | - |
| Finance Cost | - | - | - | - |
| D&A | 170 | 170 | 170 | 170 |
| EBIT | 1588 | 1544 | 1370 | - |
| EBIT Margins | 0.19 | 0.19 | 0.21 | - |
| PBT | 1200 | 1200 | 1200 | - |
| PBT Margins | 0.15 | 0.15 | 0.19 | - |
| Tax (2021) | Approx. 30% of PBT | - | - | - |
| PAT | 1229 | 1666 | 1590 | - |
| NPM | 0.15 | - | - | - |
| EPS | - | - | - | - |
| Financial Ratios | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating Profit Margin | 0.334 | 0.209 | 0.186 | 22-23% |
| Net Profit Margin | 0.316 | 0.156 | 0.189 | ~15.6% |
| Earning Per Share (Diluted) | ₹37.0 | ₹19.5 | ₹24.6 | ~₹24.64 |
Shareholding Pattern
| Shareholding Pattern | 2021 | 2022 | 2023 | 2024 |
|---|
Promoters
| Promoters | Designation | Experience | Linkedin Profile |
|---|---|---|---|
| Banwarilal Murlidhar Bawri | Director | 35+ | - |
| Girdharilal Murlidhar Bawri | Director | 14 | - |
| ajendra Murlidhar Agarwal | Director | 15 | - |
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.
